Emergent to make treatment for Prophylix Pharma; ISPE calls for quality to avoid shortages;

> Prophylix Pharma has signed an agreement with Emergent BioSolutions to manufacture a potentially new treatment for the bleeding disorder FNAIT. Release

> The International Society for Pharmaceutical Engineering (ISPE) has released its Drug Shortages Prevention Plan, calling on drugmakers to create a quality culture that will ensure a robust, resilient and reliable supply of medications. Report

> West Pharmaceutical Services ($WST) is looking for a replacement for CEO Donald Morel after he announced his plans to retire. Report

> TraceLink reports record earnings powered by drug companies complying with new track and trace requirements. Release